Sidra Medical and Research Center Selects Omnicell G4 Medication Management Solutions for Its State-of-the-Art Facility

 Sidra Medical and Research Center Selects Omnicell G4 Medication Management
                 Solutions for Its State-of-the-Art Facility

Multi-Billion Dollar New All-Digital Medical Facility to Implement Omnicell's
Advanced Medication Automation Solutions in Qatar

PR Newswire

MOUNTAIN VIEW, Calif., Jan. 28, 2013

MOUNTAIN VIEW, Calif., Jan. 28, 2013 /PRNewswire/ -- Omnicell, Inc.
(NASDAQ:OMCL), a leading provider of medication and supply management
solutions and analytics software for healthcare facilities and its partner,
Mannai Corporation, today announced that the highly anticipated, all-digital
Sidra Medical and Research Center has selected Omnicell as the exclusive
provider of automated medication management solutions throughout its facility.
Omnicell's G4 platform will serve as an integral component of Sidra's planned
wireless and virtually paperless nursing and pharmacy operations. Sidra's
mission is to provide world-class patient care along with medical education
and research. To support the achievement of these goals, the Qatar Foundation
has committed $7.9 billion, one of the largest endowments of its kind in the
world.

(Logo: http://photos.prnewswire.com/prnh/20120731/SF48971LOGO-a)

After a competitive global review process of the most advanced medication
automation technology, Omnicell's G4 platform was selected for its unique
capabilities and overall patient safety benefits. Omnicell's highly
interoperable solutions and advanced technology perfectly complement Sidra's
goals of empowering providers through easier access to information, enabling
the highest possible quality of patient care.

"As we strive to establish Sidra as one of the most modern medical facilities
in the world, it is vital that we implement a medication automation solution
that will integrate effortlessly with our other care delivery processes and
systems," said Sidra's chief of health informatics Dr. Alistair Erskine. "We
selected Omnicell's technologically advanced solutions because we are
confident that this will help fulfill our vision of providing truly
exceptional patient care. Omnicell, with its experience in the region, is an
important relationship for Sidra as we build and strengthen our reputation as
a leader in health care, medical research and academic medical training
throughout the Middle East. We look forward to cooperating with Omnicell for
many years to come."

Sidra will open with around 400 beds while putting infrastructure in place to
enable expansion to 550 beds in a subsequent phase. Sidra plans to use
Omnicell technologies throughout the facility and intends to increase
deployment over time to meet the hospital's growing needs as it expands. In
addition to the OmniRx® G4 automated medication dispensing cabinets (ADCs),
the following Omnicell technologies will be implemented:

  oOmnicell's Anesthesia Workstation™, an automated dispensing cabinet that
    improves medication security in the operating room without sacrificing
    convenient access to medications and supplies.
  oSavvy™, a mobile medication workstation designed to streamline the
    medication administration process and provide safe and secure
    transportation of medications from the ADC to the patient's bedside,
    helping nurses administer medications more quickly, saving time for other
    patient care tasks.
  oAnywhere RN™ remote medication management software, which provides nurses
    with a flexible approach to the medication administration process that
    positively impacts nursing and patient safety. It is a web-based
    application designed specifically for nurses that lets them remotely
    access the Omnicell cabinets from virtually any computer or workstation in
    the patient care area, including the Savvy mobile medication workstation.

    Study data shows that with Anywhere RN running on Savvy mobile medication
    systems or networked workstations, nurses are interrupted on average 54
    percent less during critical medication administration procedures, and
    they also spend an average of 33 percent less time doing administrative
    duties at the dispensing cabinet. Nurses are thus freed to spend more
    time focusing on their clinical work and spending time with their
    patients. ^1

"Omnicell is confident that Sidra's commitment to providing outstanding
patient care through the use of the most innovative technologies will quickly
propel them to become one of the Middle East's top health facilities. We are
honored to be selected to work with this groundbreaking medical center,
furthering our commitment to work with world-class healthcare facilities in
this rapidly growing region of the world," said Gary Ervin, Vice President
International, at Omnicell. "As an all-digital facility, the integration of
data and workflows between technologies is imperative to Sidra's success, and
we are pleased to offer a solution that can meet their needs."

"Espousing Sidra Medical Research Center's mission to provide world-class
patient care, we are extremely proud to be partnering with Omnicell to bring
in a top-notch pharmacy automation solution, which maximizes medication safety
and workflow efficiency," said Alekh Grewal, Group CEO, Mannai Corporation.
"Since its inception, Mannai Medical Division, with its team of certified
delivery and support professionals, has been constantly striving to provide
state-of-the-art medical and scientific technology solutions which are in line
with Qatar's vision to promote quality health care for its people."

About Sidra Medical & Research Center
Sidra Medical and Research Center is a groundbreaking hospital, research and
education institution, currently under construction in Doha, Qatar, that will
focus on the health and wellbeing of women and children regionally and
globally. Sidra will be a fully digital facility, incorporating the most
advanced information technology applications in clinical, research and
business functions. Sidra will initially have around 400 beds with
infrastructure to enable expansion to 550 beds in a subsequent phase.

Sidra represents the vision of Her Highness Sheikha Moza bint Nasser who
serves as its Chairperson. The high-tech facility will not only provide
world-class patient care but will also help build Qatar's scientific expertise
and resources. Sidra will be funded by a US$7.9 billion endowment from Qatar
Foundation, one of the largest endowments of its kind in the world.

Sidra is part of a dynamic research and education environment in Qatar that
includes leading international institutions, such as: Sidra's academic partner
Weill Cornell Medical College in Qatar, and Qatar Science and Technology Park.
Through strong partnerships with leading institutions around the world, Sidra
is creating an intellectual ecosystem to help advance scientific discovery
through investment in medical research.

Sidra will have a unique working structure with inter-professional
collaboration at the heart, providing the best holistic care for patients and
an unparalleled learning environment for its medical professionals. Sidra will
combine the best in design, technology, operations and practices from medical
centers around the world – to offer its employees an environment that is at
once familiar and extraordinary.

About Mannai Corporation Q.S.C.
Mannai Corporation Q.S.C. is a public company headquartered in Qatar with over
3,000 employees. Its diverse range of business areas include automotive
distribution and service, information and communication technology,
engineering services to the oil and gas sector, home appliances and
electronics, travel services, logistics, geotechnical and geological services,
facilities management, trading and commercial representation.

In the healthcare sector, Mannai Medical division offers healthcare equipment
and systems from some of the world's leading healthcare technology providers
and offers installation, commissioning, application support and post-warranty
services. A number of turnkey projects have been deployed in hospitals that
include complete Medical Gas Pipeline Systems (MGPS), Medical Architectural
System, Pneumatic Tube Systems (PTS), Automated Guided Vehicles (AGV),
Diagnostic Imaging Systems and Monitoring Devices, Scientific and Laboratory
Systems among others.

Please visit www.mannai.com for more information.

About Omnicell
For over 20 years the mission of Omnicell (NASDAQ: OMCL) has been creating new
efficiencies to improve patient care, anywhere it is delivered. Omnicell is a
leading supplier of comprehensive automation and business analytics software
solutions for patient-centric medication and supply management across the
entire healthcare continuum, from the acute care hospital setting to
post-acute skilled nursing and long-term care facilities to the home.

Since 1992, more than 2,600 Acute Care customers worldwide have utilized
Omnicell's medication automation, supply chain and analytics solutions to
increase operational efficiency, reduce errors, deliver actionable
intelligence and improve patient safety. Omnicell Non-Acute Care solutions,
under the MTS Medication Technologies brand, provide innovative medication
adherence packaging solutions that can reduce costly hospital readmissions and
enable approximately 6,000 institutional and retail pharmacies worldwide to
maintain high accuracy and quality standards in medication dispensing and
administration while optimizing productivity and controlling costs.

1.Data from Omnicell nursing surveys

OMCL - G

SOURCE Omnicell, Inc.

Website: http://www.omnicell.com
Contact: Todd Sims, Omnicell, Inc., +1-650-251-6114, todd.sims@omnicell.com;
or Gloria Montefalcon, Mannai Corporation, +974 44558868,
montefalcon@mannai.com.qa
 
Press spacebar to pause and continue. Press esc to stop.